Difficulty: Medium
Average Score: 95%
Practice
Which of the following is MOST likely considered a risk factor for extraneural metastasis in primary brain tumors?
Correct answer
A
Rationale
The correct answer is A) age less than 10 years. In pediatric patients, age less than 10 years is considered a risk factor for extraneural metastasis in primary brain tumors. Younger age is associated with a higher likelihood of tumor spread beyond the central nervous system.
Option B) female gender is not a known risk factor for extraneural metastasis in primary brain tumors. Gender does not play a significant role in predicting the likelihood of extraneural spread.
Option C) ventriculoperitoneal (VP) shunt insertion is a treatment procedure for managing hydrocephalus and is not directly linked to an increased risk of extraneural metastasis in primary brain tumors.
Option D) supratentorial tumor location does not predict extraneural metastasis risk. Tumor location may impact symptoms and treatment options but is not a primary factor in determining the likelihood of metastasis.
Educationally, understanding risk factors for extraneural metastasis in pediatric brain tumors is crucial for healthcare providers involved in the care of these patients. This knowledge can guide treatment decisions, surveillance strategies, and discussions with families regarding prognosis and potential outcomes.
Option B) female gender is not a known risk factor for extraneural metastasis in primary brain tumors. Gender does not play a significant role in predicting the likelihood of extraneural spread.
Option C) ventriculoperitoneal (VP) shunt insertion is a treatment procedure for managing hydrocephalus and is not directly linked to an increased risk of extraneural metastasis in primary brain tumors.
Option D) supratentorial tumor location does not predict extraneural metastasis risk. Tumor location may impact symptoms and treatment options but is not a primary factor in determining the likelihood of metastasis.
Educationally, understanding risk factors for extraneural metastasis in pediatric brain tumors is crucial for healthcare providers involved in the care of these patients. This knowledge can guide treatment decisions, surveillance strategies, and discussions with families regarding prognosis and potential outcomes.